Cancers | Myeloma Awareness Month
March is designated as Myeloma Awareness Month, with various global activities that highlight and increase awareness of myeloma for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of myeloma, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.
The list of relevant papers can be seen below:
1. “Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma”
by Omar Nadeem, Sikander Ailawadhi, Jack Khouri, Louis Williams, Donna Catamero, Kathryn Maples and Jesús Berdeja
Cancers 2024, 16(5), 1023; https://doi.org/10.3390/cancers16051023
Available online: https://www.mdpi.com/2072-6694/16/5/1023
2. “Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma”
by Paola Tacchetti, Simona Barbato, Katia Mancuso, Elena Zamagni and Michele Cavo
Cancers 2024, 16(13), 2337; https://doi.org/10.3390/cancers16132337
Available online: https://www.mdpi.com/2072-6694/16/13/2337
3. “Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation”
by Rebecca Sheridan, Kieran Brennan, Despina Bazou, Peter O’Gorman, David Matallanas and Margaret M. Mc Gee
Cancers 2024, 16(5), 1011; https://doi.org/10.3390/cancers16051011
Available online: https://www.mdpi.com/2072-6694/16/5/1011
4. “Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma”
by Basudev Chowdhury, Swati Garg, Wei Ni, Martin Sattler, Dana Sanchez, Chengcheng Meng, Taisei Akatsu, Richard Stone, William Forrester, Edmund Harrington et al.
Cancers 2024, 16(7), 1319; https://doi.org/10.3390/cancers16071319
Available online: https://www.mdpi.com/2072-6694/16/7/1319
5. “Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma”
by Maciej Dubaj, Karol Bigosiński, Aleksandra Dembowska, Radosław Mlak, Aneta Szudy-Szczyrek, Teresa Małecka-Massalska and Iwona Homa-Mlak
Cancers 2024, 16(5), 1033; https://doi.org/10.3390/cancers16051033
Available online: https://www.mdpi.com/2072-6694/16/5/1033
6. “Functional Investigation of IGF1R Mutations in Multiple Myeloma”
by Sofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler, Marlene Schwarzfischer, Viktoria Fuhr, Hilka Rauert-Wunderlich, Anne Krügl, Theodora Nedeva, Tina Grieb, Julia Pickert
Cancers 2024, 16(11), 2139; https://doi.org/10.3390/cancers16112139
Available online: https://www.mdpi.com/2072-6694/16/11/2139
7. “Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells’ Escape from the Bone Marrow Microenvironment”
by Stefaan W. Verbruggen, Ciara L. Freeman and Fiona E. Freeman
Cancers 2024, 16(5), 889; https://doi.org/10.3390/cancers16050889
Available online: https://www.mdpi.com/2072-6694/16/5/889
8. “The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management”
by Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia and Massimo Offidani
Cancers 2024, 16(12), 2263; https://doi.org/10.3390/cancers16122263
Available online: https://www.mdpi.com/2072-6694/16/12/2263
9. “Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation”
by Lixin Gong, Lugui Qiu and Mu Hao
Cancers 2024, 16(3), 498; https://doi.org/10.3390/cancers16030498
Available online: https://www.mdpi.com/2072-6694/16/3/498
10. “Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery”
by Julian Mehl, Dilara Akhoundova, Ulrike Bacher, Barbara Jeker, Gaëlle Rhyner Agocs, Axel Ruefer, Susanne Soltermann, Martin Soekler, Annette Winkler, Michael Daskalakis et al.
Cancers 2024, 16(10), 1854; https://doi.org/10.3390/cancers16101854
Available online: https://www.mdpi.com/2072-6694/16/10/1854
11. “Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients”
by Omar S. Al-Odat, Emily Nelson, Tulin Budak-Alpdogan, Subash C. Jonnalagadda, Dhimant Desai and Manoj K. Pandey
Cancers 2024, 16(13), 2381; https://doi.org/10.3390/cancers16132381
Available online: https://www.mdpi.com/2072-6694/16/13/2381
12. “A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation”
by Wancheng Guo, Christopher Strouse, David Mery, Eric R. Siegel, Manit N. Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang et al.
Cancers 2024, 16(6), 1116; https://doi.org/10.3390/cancers16061116
Available online: https://www.mdpi.com/2072-6694/16/6/1116
13. “Effects on the Physical Functioning of Two Exercise Interventions in Patients with Multiple Myeloma: A Pilot Feasibility Study”
by Jens Hillengass, Michaela Hillengass, Janine M. Joseph, Kristopher Attwood, Rikki Cannioto, Hillary Jacobson, Carolyn Miller, Bryan Wittmeyer and Kirsten Moysich
Cancers 2024, 16(9), 1774; https://doi.org/10.3390/cancers16091774
Available online: https://www.mdpi.com/2072-6694/16/9/1774
14. “IL1B Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients”
by Marcin Mazurek, Aneta Szudy-Szczyrek, Iwona Homa-Mlak, Marek Hus, Teresa Małecka-Massalska and Radosław Mlak
Cancers 2024, 16(7), 1263; https://doi.org/10.3390/cancers16071263
Available online: https://www.mdpi.com/2072-6694/16/7/1263
by Kevin Guanwen Shim and Rafael Fonseca
Cancers 2024, 16(19), 3288; https://doi.org/10.3390/cancers16193288
Available online: https://www.mdpi.com/2072-6694/16/19/3288
You are welcome to submit relevant papers to the journal Cancers.
Cancers Editorial Office